Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience

@article{Konttinen2007AntiTNFTI,
  title={Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience},
  author={Liisa M Konttinen and Riitta Tuompo and Tea Uusitalo and Riitta Luosuj{\"a}rvi and Kari Laiho and Jukka P L{\"a}hteenm{\"a}ki and Maija Puurtinen-Vilkki and Ritva Lanteri and Saara Kortelainen and Helena Karilainen and Tuire Varjolahti-Lehtinen and Dan C. E. Nordstr{\"o}m},
  journal={Clinical Rheumatology},
  year={2007},
  volume={26},
  pages={1693-1700}
}
Biological therapy for ankylosing spondylitis (AS) has led to improved disease control beyond that of conventional treatments. International recommendations encourage clinicians prescribing biological treatments to register patients in national registers to collect information on outcome and toxicity. Patients with AS (n = 229) from the Register of Biological Treatment in Finland (ROB-FIN) with severe disease of long duration were followed-up for up to 24 months. Due to an active disease, one… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)

D van der Heijde, B Dijkmans, P Geusens
  • Arthritis Rheum
  • 2005
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis

T Pham, R Landewe, S van der Linden
  • Ann Rheum
  • 2006
VIEW 1 EXCERPT

Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events

L. Konttinen, V. Honkanen, +9 authors for the ROB-FIN study group
  • Rheumatology International
  • 2005
VIEW 2 EXCERPTS

Similar Papers

Loading similar papers…